Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Amlodipine and Olmesartan Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Amlodipine and Olmesartan Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Amlodipine and Olmesartan Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Amlodipine and Olmesartan Market Size Growth Rate by Type
    • 1.4.2 5/20 mg Tablets
    • 1.4.3 10/20 mg Tablets
    • 1.4.4 5/40 mg Tablets
    • 1.4.5 10/40 mg Tablets
  • 1.5 Market by Application
    • 1.5.1 Global Amlodipine and Olmesartan Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Drug store
  • 1.6 Coronavirus Disease 2019 (Covid-19): Amlodipine and Olmesartan Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Amlodipine and Olmesartan Industry
      • 1.6.1.1 Amlodipine and Olmesartan Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Amlodipine and Olmesartan Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Amlodipine and Olmesartan Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Amlodipine and Olmesartan Market Size Estimates and Forecasts
    • 2.1.1 Global Amlodipine and Olmesartan Revenue 2015-2026
    • 2.1.2 Global Amlodipine and Olmesartan Sales 2015-2026
  • 2.2 Amlodipine and Olmesartan Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Amlodipine and Olmesartan Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Amlodipine and Olmesartan Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Amlodipine and Olmesartan Competitor Landscape by Players

  • 3.1 Amlodipine and Olmesartan Sales by Manufacturers
    • 3.1.1 Amlodipine and Olmesartan Sales by Manufacturers (2015-2020)
    • 3.1.2 Amlodipine and Olmesartan Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Amlodipine and Olmesartan Revenue by Manufacturers
    • 3.2.1 Amlodipine and Olmesartan Revenue by Manufacturers (2015-2020)
    • 3.2.2 Amlodipine and Olmesartan Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Amlodipine and Olmesartan Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Amlodipine and Olmesartan Revenue in 2019
    • 3.2.5 Global Amlodipine and Olmesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Amlodipine and Olmesartan Price by Manufacturers
  • 3.4 Amlodipine and Olmesartan Manufacturing Base Distribution, Product Types
    • 3.4.1 Amlodipine and Olmesartan Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Amlodipine and Olmesartan Product Type
    • 3.4.3 Date of International Manufacturers Enter into Amlodipine and Olmesartan Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Amlodipine and Olmesartan Market Size by Type (2015-2020)
    • 4.1.1 Global Amlodipine and Olmesartan Sales by Type (2015-2020)
    • 4.1.2 Global Amlodipine and Olmesartan Revenue by Type (2015-2020)
    • 4.1.3 Amlodipine and Olmesartan Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Amlodipine and Olmesartan Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Amlodipine and Olmesartan Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Amlodipine and Olmesartan Revenue Forecast by Type (2021-2026)
    • 4.2.3 Amlodipine and Olmesartan Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Amlodipine and Olmesartan Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Amlodipine and Olmesartan Market Size by Application (2015-2020)
    • 5.1.1 Global Amlodipine and Olmesartan Sales by Application (2015-2020)
    • 5.1.2 Global Amlodipine and Olmesartan Revenue by Application (2015-2020)
    • 5.1.3 Amlodipine and Olmesartan Price by Application (2015-2020)
  • 5.2 Amlodipine and Olmesartan Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Amlodipine and Olmesartan Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Amlodipine and Olmesartan Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Amlodipine and Olmesartan Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Amlodipine and Olmesartan by Country
    • 6.1.1 North America Amlodipine and Olmesartan Sales by Country
    • 6.1.2 North America Amlodipine and Olmesartan Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Amlodipine and Olmesartan Market Facts & Figures by Type
  • 6.3 North America Amlodipine and Olmesartan Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Amlodipine and Olmesartan by Country
    • 7.1.1 Europe Amlodipine and Olmesartan Sales by Country
    • 7.1.2 Europe Amlodipine and Olmesartan Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Amlodipine and Olmesartan Market Facts & Figures by Type
  • 7.3 Europe Amlodipine and Olmesartan Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Amlodipine and Olmesartan by Region
    • 8.1.1 Asia Pacific Amlodipine and Olmesartan Sales by Region
    • 8.1.2 Asia Pacific Amlodipine and Olmesartan Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Amlodipine and Olmesartan Market Facts & Figures by Type
  • 8.3 Asia Pacific Amlodipine and Olmesartan Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Amlodipine and Olmesartan by Country
    • 9.1.1 Latin America Amlodipine and Olmesartan Sales by Country
    • 9.1.2 Latin America Amlodipine and Olmesartan Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Amlodipine and Olmesartan Market Facts & Figures by Type
  • 9.3 Central & South America Amlodipine and Olmesartan Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Amlodipine and Olmesartan by Country
    • 10.1.1 Middle East and Africa Amlodipine and Olmesartan Sales by Country
    • 10.1.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Amlodipine and Olmesartan Market Facts & Figures by Type
  • 10.3 Middle East and Africa Amlodipine and Olmesartan Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Daiichi Sankyo
    • 11.1.1 Daiichi Sankyo Corporation Information
    • 11.1.2 Daiichi Sankyo Description, Business Overview and Total Revenue
    • 11.1.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Daiichi Sankyo Amlodipine and Olmesartan Products Offered
    • 11.1.5 Daiichi Sankyo Recent Development
  • 11.2 Teva
    • 11.2.1 Teva Corporation Information
    • 11.2.2 Teva Description, Business Overview and Total Revenue
    • 11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Teva Amlodipine and Olmesartan Products Offered
    • 11.2.5 Teva Recent Development
  • 11.3 Glenmark Pharmaceuticals
    • 11.3.1 Glenmark Pharmaceuticals Corporation Information
    • 11.3.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.3.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Products Offered
    • 11.3.5 Glenmark Pharmaceuticals Recent Development
  • 11.4 Matrix Laboratories
    • 11.4.1 Matrix Laboratories Corporation Information
    • 11.4.2 Matrix Laboratories Description, Business Overview and Total Revenue
    • 11.4.3 Matrix Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Matrix Laboratories Amlodipine and Olmesartan Products Offered
    • 11.4.5 Matrix Laboratories Recent Development
  • 11.5 Torrent Pharmaceuticals
    • 11.5.1 Torrent Pharmaceuticals Corporation Information
    • 11.5.2 Torrent Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.5.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Products Offered
    • 11.5.5 Torrent Pharmaceuticals Recent Development
  • 11.6 Aurobindo
    • 11.6.1 Aurobindo Corporation Information
    • 11.6.2 Aurobindo Description, Business Overview and Total Revenue
    • 11.6.3 Aurobindo Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Aurobindo Amlodipine and Olmesartan Products Offered
    • 11.6.5 Aurobindo Recent Development
  • 11.7 Macleods Pharmaceuticals
    • 11.7.1 Macleods Pharmaceuticals Corporation Information
    • 11.7.2 Macleods Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.7.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Products Offered
    • 11.7.5 Macleods Pharmaceuticals Recent Development
  • 11.8 Alembic Pharmaceuticals
    • 11.8.1 Alembic Pharmaceuticals Corporation Information
    • 11.8.2 Alembic Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.8.3 Alembic Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Products Offered
    • 11.8.5 Alembic Pharmaceuticals Recent Development
  • 11.9 Ajanta Pharma
    • 11.9.1 Ajanta Pharma Corporation Information
    • 11.9.2 Ajanta Pharma Description, Business Overview and Total Revenue
    • 11.9.3 Ajanta Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Ajanta Pharma Amlodipine and Olmesartan Products Offered
    • 11.9.5 Ajanta Pharma Recent Development
  • 11.10 Jubilant Pharma
    • 11.10.1 Jubilant Pharma Corporation Information
    • 11.10.2 Jubilant Pharma Description, Business Overview and Total Revenue
    • 11.10.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Jubilant Pharma Amlodipine and Olmesartan Products Offered
    • 11.10.5 Jubilant Pharma Recent Development
  • 11.1 Daiichi Sankyo
    • 11.1.1 Daiichi Sankyo Corporation Information
    • 11.1.2 Daiichi Sankyo Description, Business Overview and Total Revenue
    • 11.1.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Daiichi Sankyo Amlodipine and Olmesartan Products Offered
    • 11.1.5 Daiichi Sankyo Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Amlodipine and Olmesartan Market Estimates and Projections by Region
    • 12.1.1 Global Amlodipine and Olmesartan Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Amlodipine and Olmesartan Revenue Forecast by Regions 2021-2026
  • 12.2 North America Amlodipine and Olmesartan Market Size Forecast (2021-2026)
    • 12.2.1 North America: Amlodipine and Olmesartan Sales Forecast (2021-2026)
    • 12.2.2 North America: Amlodipine and Olmesartan Revenue Forecast (2021-2026)
    • 12.2.3 North America: Amlodipine and Olmesartan Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Amlodipine and Olmesartan Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Amlodipine and Olmesartan Sales Forecast (2021-2026)
    • 12.3.2 Europe: Amlodipine and Olmesartan Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Amlodipine and Olmesartan Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Amlodipine and Olmesartan Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Amlodipine and Olmesartan Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Amlodipine and Olmesartan Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Amlodipine and Olmesartan Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Amlodipine and Olmesartan Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Amlodipine and Olmesartan Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Amlodipine and Olmesartan Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Amlodipine and Olmesartan Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Amlodipine and Olmesartan Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Amlodipine and Olmesartan Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Amlodipine and Olmesartan Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Amlodipine and Olmesartan Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Amlodipine and Olmesartan Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Amlodipine and Olmesartan Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Amlodipine and Olmesartan market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine and Olmesartan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Amlodipine and Olmesartan market is segmented into
    5/20 mg Tablets
    10/20 mg Tablets
    5/40 mg Tablets
    10/40 mg Tablets

    Segment by Application, the Amlodipine and Olmesartan market is segmented into
    Hospital
    Drug store

    Regional and Country-level Analysis
    The Amlodipine and Olmesartan market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Amlodipine and Olmesartan market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Amlodipine and Olmesartan Market Share Analysis
    Amlodipine and Olmesartan market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Amlodipine and Olmesartan business, the date to enter into the Amlodipine and Olmesartan market, Amlodipine and Olmesartan product introduction, recent developments, etc.
    The major vendors covered:
    Daiichi Sankyo
    Teva
    Glenmark Pharmaceuticals
    Matrix Laboratories
    Torrent Pharmaceuticals
    Aurobindo
    Macleods Pharmaceuticals
    Alembic Pharmaceuticals
    Ajanta Pharma
    Jubilant Pharma
    Accord Healthcare

    Buy now